The Latest in Psoriatic Arthritis ICYMI

Apremilast may have some cardiometabolic benefits in patients with psoriasis

September 27, 2022

Psoriatic Arthritis

Psoriasis, psoriatic arthritis insurance coverage remains restrictive

September 26, 2022

Psoriatic Arthritis

Apremilast alleviates severe psoriasis in some children, data show

September 20, 2022

Psoriatic Arthritis

Brodalumab suicide risk similar to other biologics, postmarket study finds

September 19, 2022

Psoriatic Arthritis

Elbow tenderness and swollen joints

September 19, 2022

Psoriatic Arthritis

PsA: Sustained improvement in dactylitis with tofacitinib

September 16, 2022

Psoriatic Arthritis

PsA: Sustained improvement in dactylitis with tofacitinib

September 16, 2022

Psoriatic Arthritis

Precision medicine based on peripheral T-lymphocyte phenotyping is effective in the real world

September 16, 2022

Psoriatic Arthritis

PEST and BMI predict development of PsA in psoriasis patients

September 16, 2022

Psoriatic Arthritis

Flares increase disease burden in PsA

September 16, 2022

Psoriatic Arthritis

More side effects with methotrexate in PsA vs RA patients

September 16, 2022

Psoriatic Arthritis

PsA: Women experience greater disease burden than men

September 16, 2022

Psoriatic Arthritis

PsA: Women experience greater disease burden than men

September 16, 2022

Psoriatic Arthritis

How useful is CRP as a marker for assessing disease activity in PsA?

September 16, 2022

Psoriatic Arthritis

How useful is CRP as a marker for assessing disease activity in PsA?

September 16, 2022

Psoriatic Arthritis